Pharmaceutical News and Articles

Zepbound (tirzepatide), the Most Prescribed Weight Management Medication in 2025, Now Available in Multi-Dose KwikPen

Eli Lilly and Company (NYSE LLY) today announced the U.S. Food and Drug Administration (FDA) approved a label expansion for Zepbound (tirzepatide) to include th

FDA Accepts New Drug Application for Genentech’s Giredestrant in ESR1-Mutated, ER-Positive Advanced Breast Cancer

Garetosmab Biologics License Application Accepted for FDA Priority Review for the Treatment of Fibrodysplasia Ossificans Progressiva (FOP)

Calquence Plus Venetoclax Approved in the US as First All-Oral, Fixed-Duration Combination for Patients with Chronic Lymphocytic Leukemia in the 1st-Line Setting

FDA Approves Bysanti (milsaperidone) for the treatment of Bipolar I Disorder and Schizophrenia

Results Outweigh Side Effects Among Ozempic/Wegovy Users, Study Says

MONDAY, Feb. 23, 2026 Side effects like nausea or vomiting are common among folks taking Ozempic Wegovy, but they ll grin and bear it if they think they re losi

Cancer Blood Test Fails to Catch Disease Earlier in Major Study

MONDAY, Feb. 23, 2026 A blood test designed to find cancer early did not work as hoped in a major new study, according to the company that makes it. The test, c

Trader Joe’s Recalls Chicken Fried Rice Over Possible Glass Pieces

MONDAY, Feb. 23, 2026 Trader Joe s shoppers are being urged to check their freezers amid a nationwide recall of ready-to-eat chicken fried rice due to possible

Trump Order Backing Popular Weedkiller, Glyphosate, Sparks Backlash From MAHA

MONDAY, Feb. 23, 2026 President Donald Trump has signed an executive order intended to increase U.S. production of the active ingredient in the common weedkille

Study Looks at Characteristics of Injection Drug Use-Linked Endophthalmitis

Clinical features and outcomes of injection drug use-associated endogenous endophthalmitis (IDU-EE) are described in a study published online Jan. 13 in Ophthal